e-learning
resources
Vienna 2012
Monday, 03.09.2012
Asthma and COPD: understanding through mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating mature and progenitor eosinophils in patients with stable asthma express all major traffic related receptors
Y. Lu, C. Malmhäll, M. Sjöstrand, M. Rådinger, B. Lundbäck, J. Lötvall, A. Bossios (Gothenburg, Sweden)
Source:
Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Session:
Asthma and COPD: understanding through mechanisms
Session type:
Thematic Poster Session
Number:
2308
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Lu, C. Malmhäll, M. Sjöstrand, M. Rådinger, B. Lundbäck, J. Lötvall, A. Bossios (Gothenburg, Sweden). Circulating mature and progenitor eosinophils in patients with stable asthma express all major traffic related receptors. Eur Respir J 2012; 40: Suppl. 56, 2308
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007
Decreased number of circulating endothelial progenitor cells in patients with emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells
Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease
Year: 2004
The expression of TSLP in monocyte derived dendritic cells in the interactions between respiratory epithelium and macrophages in asthma, COPD and healthy controls
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019
Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Generation from peripheral blood CD34
+
progenitors of a novel NK-2 subset that produces IL-21 and renders tolerogenic myeloid dendritic cells. A paradox for allergy treatment?
Source: Eur Respir J 2007; 30: Suppl. 51, 135s
Year: 2007
Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Reduced numbers of bronchial mature dendritic cells in COPD
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008
Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 453s
Year: 2004
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Reduced numbers of circulating CD4
+
CD25
high
FOXP3
+
regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Pulmonary inflammatory cells strongly express IL-18 in asthma death cases
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
Normal T cell expressed and secreted (RANTES): a marker of asthmatic inflammation?
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004
The fraction of circulating type 2 innate lymphoid cells in peripheral blood is associated with asthma severity
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Source: Eur Respir J 2010; 36: 1284-1293
Year: 2010
Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Triggering receptor expressed on myeloid cells (TREM)-1 and its soluble form (sTREM-1) as a diagnostic marker of bacterial lung infection
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors
Source: Eur Respir J 2003; 22: Suppl. 45, 291s
Year: 2003
Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept